Search results
Results from the WOW.Com Content Network
10–50 mg 2–3x/week Testosterone enanthate: Delatestryl: Oil solution: 50–250 mg 1x/1–4 weeks Xyosted: Auto-injector: 50–100 mg 1x/week Testosterone cypionate: Depo-Testosterone: Oil solution: 50–250 mg 1x/1–4 weeks Testosterone isobutyrate: Agovirin Depot: Aqueous suspension: 50–100 mg 1x/1–2 weeks Testosterone phenylacetate b
Testosterone may prove to be an effective treatment in female sexual arousal disorders, [80] and is available as a dermal patch. There is no FDA-approved androgen preparation for the treatment of androgen insufficiency; however, it has been used as an off-label use to treat low libido and sexual dysfunction in older women. Testosterone may be a ...
Testosterone propionate. Testosterone propionate, sold under the brand name Testoviron among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. [4][1][5] It has also been used to treat breast cancer in women. [6]
25–50 mg 1x/6–12 weeks Prasterone enanthate a: Gynodian Depot: Oil solution: 200 mg 1x/4–6 weeks Implant: Testosterone: Testopel: Pellet: 50–100 mg 1x/3–6 months Notes: Premenopausal women produce about 230 ± 70 μg testosterone per day (6.4 ± 2.0 mg testosterone per 4 weeks), with a range of 130 to 330 μg per day (3.6–9.2 mg per ...
[115] [116] The combination of 25 mg/day cyproterone acetate and a moderate dosage of estradiol has been found to suppress testosterone levels in transgender women by about 95%. [117] In combination with estrogen, 10, 25, and 50 mg/day cyproterone acetate have all shown the same degree of testosterone suppression. [118]
Vosilasarm has been assessed in clinical trials in women with breast cancer at doses ranging from 50 to 150 mg/day, with the maximum safe and tolerated dose being 100 mg/day. [ 10 ] [ 3 ] [ 2 ] The drug sold via black-market Internet suppliers and used non-medically has been reported to be taken at doses of 5 to 30 mg/day, with unknown adverse ...
25–50 mg 1x/6–12 weeks Prasterone enanthate a: Gynodian Depot: Oil solution: 200 mg 1x/4–6 weeks Implant: Testosterone: Testopel: Pellet: 50–100 mg 1x/3–6 months Notes: Premenopausal women produce about 230 ± 70 μg testosterone per day (6.4 ± 2.0 mg testosterone per 4 weeks), with a range of 130 to 330 μg per day (3.6–9.2 mg per ...
A study by Fung and colleagues (2017) found no difference in suppression of circulating testosterone levels (~95% suppression) in transgender women by the combination of either 25 mg/day oral CPA or 50 mg/day oral CPA with a moderate dosage of oral or transdermal estradiol (mean 3.3 mg/day oral, 3.4 g/day gel, or 95.6 μg/day patches). [150]